Difference between revisions of "DZI20-199-Case-6"

From MGH Learn Pathology
(Automatic edit to upgrade to new templates)
(Updating subject, access, and performer)
Line 16: Line 16:
 
FX3: pancreatic transection margin
 
FX3: pancreatic transection margin
 
FX4: Mass to uncinate
 
FX4: Mass to uncinate
|subject=public
+
|subject=MGH
|performer=Vd019
+
|performer=VD019
 
|authoredOn=December 12, 2020 05:40:26 PM
 
|authoredOn=December 12, 2020 05:40:26 PM
 
|requester=Mjf79
 
|requester=Mjf79
 
|sequence=6
 
|sequence=6
 +
|access=public
 
}}
 
}}
 
{{Media
 
{{Media

Revision as of 15:06, June 21, 2022

DZI20-199-Case-6
pancreas mass - whipple

FX2: common bile duct margin FX3: pancreatic transection margin

FX4: Mass to uncinate
FX2 (common bile duct margin): TINEM

FX3 (pancreatic transection margin): TINEM (permanent: chronic pancreatitis)

FX4 (Mass to uncinate): adenocarcinoma, viable cells are present. Uncinate margin, negative for tumor (permanent: ductal adenocarcinoma)
December 31, 1969 7:00:00 PM